期刊文献+

医保药品支付标准动态管理机制及关键因素探讨 被引量:1

Discussion on Dynamic Management Mechanism and Key Factors of Medical Insurance Drugs Payment Standard
下载PDF
导出
摘要 医保药品支付标准制定的一大关键问题在于,如何形成科学、合理的动态管理机制。本文旨在通过相关国际经验的分析,探讨形成医保药品支付标准动态管理机制的模式,分析其中应当考虑的关键因素,以期为完善我国的医保药品支付标准动态管理机制、促进医保支付制度改革提供参考。 A key issue in the setting of medical insurance drugs payment standard lies in how to form a scientific and rational dynamic management. The purpose of this paper is to explore the mode of dynamic management for medical insurance drugs payment standard through the related international experience, analyze the key factors that ought to be considered and then provide a reference for improving the dynamic management of medical insurance drugs payment standard as well as promoting the reform of medical insurance payment system in China.
出处 《中国医疗保险》 2018年第1期67-70,共4页 China Health Insurance
关键词 医保药品支付标准 动态管理 关键因素 medical insurance drugs payment standard, dynamic management mechanism, key factors
  • 相关文献

参考文献3

二级参考文献32

  • 1董文勇.德国社会医疗保险用药费用控制制度及其对中国的启示[J].环球法律评论,2006,28(2):208-217. 被引量:24
  • 2G-BA. Reference prices and how they are set [ EB/OL]. [ 2015-01-23 ]. https://www, g-ba. de/institution/themen- schwerpunkte/arzneimittel/festbetrag/.
  • 3G-BA. Decisions on Healthcare Benefits[ EB/OL]. [2014- 10-23 ]. http://www, english, g-ba. de/structure/.
  • 4Paris V, Docteur E. Pharmaceutical pricing and reimburse- ment policies in Germany [ R ]. Organisation for Economic Co-operation and Development, 2008.
  • 5G-BA. Arzneimittel-Riehtlinie [ EB/OL]. [ 2015-03-11 ] https://www, g-ba. de/informationen/richtlinien/anlage/7/.
  • 6Petkantchin V. Economic effects of Germany's reference pri- cing policy for drugs [ J ]. Institut 6conomique Molinari, Brussels, 2006 : 1-20.
  • 7DIMDI. Arzneimittel-Festbetrtge [ EB/OL ]. [ 2015-04- 15 1. http ://www. dimdi, de/static/de/amg/festbetraege- zuzahlung/festbetraege/index, htm.
  • 8Herr A, Supplier M. Pharmaceutical prices under regula- tion: Tiered co-payments and reference pricing in Germany [ M]. DICE Discussion Paper, 2012.
  • 9Danzon P M, Ketcham J D. Reference pricing of pharma- ceuticals for Medicare: evidence from Germany, The Neth- erlands, and New Zealand [ C ]//Forum for Health Eco- nomics & Policy. 2004.
  • 10G-BA. Arzneimittelpreisverordnung ( AMPreisV ) [ EB/OL ]. [ 2014-03-27 ]. http://www, gesetze-im-internet, de/am- preisv/BJNR021470980, html.

共引文献54

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部